Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
August 29 2023 - 6:35AM
Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage
pharmaceutical company focused on the development and
commercialization of therapies for patients with rare genetic
mitochondrial diseases, today announced that the company’s
management team will participate at the upcoming healthcare
investor conferences.
Citi BioPharma ConferenceDate: Wednesday,
September 6 – Thursday, September 7, 2023Location: Four Seasons,
Boston, MA
Baird Global Healthcare ConferenceDate:
Tuesday, September 12 – Wednesday, September 13, 2023Location:
InterContinental New York Barclay, New York, NY
Leerink Partners Biopharma SummitDate:
Wednesday, September 20 – Friday, September 22, 2023 Location:
Rosewood Miramar Beach, Montecito, CA
Cantor Global Healthcare ConferenceDate:
Tuesday, September 26 – Thursday, September 28, 2023Location:
InterContinental New York Barclay, New York, NY
Links to the presentations will be posted on
the Investors section of the Reneo Pharmaceuticals
corporate website.
About Reneo PharmaceuticalsReneo is a
clinical-stage pharmaceutical company focused on the development
and commercialization of therapies for patients with rare genetic
mitochondrial diseases, which are often associated with the
inability of mitochondria to produce adenosine triphosphate (ATP).
Our lead product candidate, mavodelpar (REN001), is a potent and
selective agonist of the peroxisome proliferator-activated receptor
delta (PPARδ). Mavodelpar has been shown to increase transcription
of genes involved in mitochondrial function, increase fatty acid
oxidation, and may increase production of new mitochondria. For
additional information, please see reneopharma.com.
Contacts:
Danielle Spangler Investor Relations Reneo
Pharmaceuticals, Inc. dspangler@reneopharma.com
Matthew Purcell, Pharm.D.Media Inquiries Russo Partners,
LLC matthew.purcell@russopartnersllc.com
Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
From Sep 2023 to Sep 2024